Related Experiment Video
Updated: Mar 19, 2026

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center
Kenneth D Katz1, Adam L Leonetti1, Blake C Bailey1
1Department of Emergency Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania.
Abstract:
Synthetic cannabinoid use has risen at alarming rates. This case series describes 11 patients exposed to the synthetic cannabinoid, MAB-CHMINACA who presented to an emergency department with life-threatening toxicity including obtundation, severe agitation, seizures and death. All patients required sedatives for agitation, nine required endotracheal intubation, three experienced seizures, and one developed hyperthermia. One developed anoxic brain injury, rhabdomyolysis and died. A significant number were pediatric patients. The mainstay of treatment was aggressive sedation and respiratory support. Synthetic cannabinoids pose a major public health risk. Emergency physicians must be aware of their clinical presentation, diagnosis and treatment.
Related Concept Videos
Drug Toxicity: Overview
Toxidromes: Clinical Features
Pharmaceutical Poisoning: Potential Scenarios
Drug Toxicity: Risk factors
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Dose-Dependent Reactions

